Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senators Press Device Industry On Excessive Payments To Consulting Docs

This article was originally published in The Gray Sheet

Executive Summary

Democrats on the Senate Special Committee on Aging grilled device industry representatives at a Feb. 27 hearing about the extent and depth of payments made to physicians for consultancies and educational grants

You may also be interested in...



Sens. Leahy, Kyl To Continue Push For Patent Reform In Next Congress

Encouraged by Nov. 4 election results that increased the number of Democrats in the Senate, Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., will reintroduce his controversial patent reform bill in 2009, committee staff said

Sens. Leahy, Kyl To Continue Push For Patent Reform In Next Congress

Encouraged by Nov. 4 election results that increased the number of Democrats in the Senate, Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., will reintroduce his controversial patent reform bill in 2009, committee staff said

Device Firm PACs Give $3.08 Million To Congressional Candidates

Device companies have given a total of $3.08 million to congressional candidates this election season. The top 10 contributors gave $2.3 million, according to records drawn from Federal Election Commission filings and compiled by the Center for Responsive Politics' OpenSecrets.org Web site

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel